Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Qiaomu Huang"'
Publikováno v:
Kidney & Blood Pressure Research, Pp 1-10 (2022)
Background: The phase III clinical trial of the nonsteroidal mineralocorticoid receptor antagonist finerenone (BAY 94-8862) has been completed, aiming to investigate renal and cardiovascular outcomes in type 2 diabetes (T2D) with chronic kidney disea
Externí odkaz:
https://doaj.org/article/72345afc662f4deb9963823d0eb6c6f9
Autor:
Ao Shen, Qiaomu Huang
Publikováno v:
Contemporary Education & Teaching Research; 2023, Vol. 4 Issue 9, p427-433, 7p
Publikováno v:
ACS Biomaterials Science & Engineering. 5:2030-2040
The integration of nanomaterials with clinical therapeutic instruments is a promising approach to improve the effects of nanomaterials. We reported an efficient synergistic antibacterial strategy formed through the combination of Ag/ZnO nanocomposite
Publikováno v:
ACS biomaterials scienceengineering. 5(4)
The integration of nanomaterials with clinical therapeutic instruments is a promising approach to improve the effects of nanomaterials. We reported an efficient synergistic antibacterial strategy formed through the combination of Ag/ZnO nanocomposite
Publikováno v:
Archives of Oral Biology. 111:104640
Objective Streptococcus mutans (S. mutans), the main pathogen of dental caries, could be well killed by Ag/ZnO nanocomposite. However, effects on virulence factors remain to be elucidated. This study investigated effects of Ag/ZnO at sub-minimum inhi
Publikováno v:
Journal of materials science. Materials in medicine. 28(1)
Dental caries is a widespread disease mainly caused by the anaerobic oral pathogen Streptococcus mutans (S. mutans). Ag/ZnO nanocomposite is an efficient antibacterial agent because of its high antibacterial activity and low cytotoxicity. In this stu